TELA Bio (TELA) Exchange Rate Effect (2019 - 2026)
TELA Bio's (TELA) quarterly Exchange Rate Effect came in at -$26000.0 in Q1 2026, up 80.6% year-on-year from -$14396.7 in Q1 2025, and up 25.71% quarter-over-quarter from -$35000.0 in Q4 2025.
TELA Bio (TELA) Exchange Rate Effect (2019 - 2026) Analysis & Trends
TELA Bio's Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$26000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 80.6% year-over-year to -$26000.0 in Q1 2026; TTM through Mar 2026 was -$109000.0, a 28.29% increase from a year earlier, with the FY2025 full-year figure at -$217000.0, down 875.0% from the prior year.
- Exchange Rate Effect advanced to -$26000.0 in Q1 2026 per TELA's latest filing, from -$35000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $182000.0 in Q4 2024 and bottomed at -$188000.0 in Q3 2024.
- The 5-year median for Exchange Rate Effect is -$12000.0 (2024), against an average of -$11470.6.
- Biggest YoY gain for Exchange Rate Effect was 2150.0% in 2022; the steepest drop was 5400.0% in 2022.
- Year by year, Exchange Rate Effect stood at $41000.0 in 2022, then tumbled by 65.85% to $14000.0 in 2023, then jumped by 1200.0% to $182000.0 in 2024, then sank by 119.23% to -$35000.0 in 2025, then gained by 25.71% to -$26000.0 in 2026.
- Per Business Quant, the three latest TELA Exchange Rate Effect figures stand at -$26000.0 (Q1 2026), -$35000.0 (Q4 2025), and $104000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | -26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26,000.00 |
| Mar 31, 2026 | -26,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | 104,000.00 |
| Sep 30, 2025 | 104,000.00 |
| Jun 30, 2025 | -152,000.00 |
| Jun 30, 2025 | -152,000.00 |
| Mar 31, 2025 | -134,000.00 |
| Mar 31, 2025 | -134,000.00 |
| Dec 31, 2024 | 182,000.00 |
| Dec 31, 2024 | 182,000.00 |
| Sep 30, 2024 | -188,000.00 |
| Sep 30, 2024 | -188,000.00 |
| Jun 30, 2024 | -12,000.00 |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |